U.S. Other Utilities Stock News

In January 2026, Revvity issued revenue guidance indicating expected fourth-quarter 2025 sales of approximately US$772 million and full-year 2025 revenue of about US$2.86 billion, alongside mid-single-digit reported and organic growth versus the prior year. Separately, Revvity announced a collaboration with Eli Lilly to integrate Lilly’s TuneLab AI models into the Revvity Signals platform, aiming to broaden access to advanced, privacy-preserving AI tools for drug discovery across the biotech...

Teledyne Technologies (TDY) is back in focus after its imaging hardware successfully launched on NASA’s BlackCAT CubeSat mission, just as investors look ahead to the company’s Q4 2025 earnings report this week. See our latest analysis for Teledyne Technologies. Teledyne’s recent contract wins in defense imaging, its BlackCAT CubeSat success and investor outreach at the Needham Growth Conference have arrived alongside a 30 day share price return of 11.02% and a 1 year total shareholder return...

Options jitters and a 10% slide put PDD in focus PDD Holdings (PDD) shares recently fell 10.08% as options trading turned cautious ahead of the March 19 earnings report, with heavier put activity and bursts of call volume signaling disagreement about what comes next. See our latest analysis for PDD Holdings. That options driven pullback comes after a tougher stretch, with the share price down 19.68% over 90 days and 9.75% year to date, while the 1 year total shareholder return is roughly flat...

Interactive Brokers Group launched stablecoin account funding for global clients, allowing deposits to be credited around the clock. The move gives customers quicker access to trading, including outside traditional banking hours and across borders. The new funding option aims to reduce delays and friction tied to international wire transfers. Interactive Brokers Group, trading as NasdaqGS:IBKR, is rolling out this stablecoin funding feature as its shares trade around $71.51. The stock shows...

Sprouts Farmers Market has faced multiple securities class action lawsuits over allegedly overstated growth claims, even as it continues to highlight rapid store expansion, strong same-store sales trends and prepares to report its fourth-quarter and full-year 2025 results on February 19, 2026. This combination of legal scrutiny and an ambitious growth rollout, funded with solid cash flows and supported by a sizable buyback program, is creating a complex backdrop for investors assessing the...

Earlier in January 2026, Ultragenyx Pharmaceutical raised its 2025 total revenue guidance to a range of US$672,000,000 to US$674,000,000, indicating approximately 20% growth versus 2024 and exceeding its prior guidance range. This higher outlook, shared around the time of management’s presentation at the 44th Annual J.P. Morgan Healthcare Conference, signals increased confidence in the company’s rare disease portfolio and commercial execution. Next, we’ll explore how Ultragenyx’s higher 2025...

Event context and recent share performance Viper Energy (VNOM) has drawn investor attention after a year in which the stock showed a 21.3% total return decline, alongside shorter term moves over the past week, month, and past 3 months. With the shares last closing at US$37.28, and recent annual revenue of US$1.13b and net income of US$244.25m, many investors are rechecking how this royalty focused oil and gas name fits into their broader energy exposure. See our latest analysis for Viper...

Ciena recently highlighted continued benefits from rising network traffic, cloud adoption and bandwidth demand, supported by a robust outlook, a US$5.00 billion backlog and the 2025 acquisition of Nubis to bolster high-performance, low-power interconnects for AI workloads. An interesting angle is how Ciena’s mix of AI-focused interconnect technology and cost-control efforts could reshape its role in future data center infrastructure. We’ll now examine how Ciena’s AI-focused Nubis acquisition...

CrowdStrike Holdings (NasdaqGS:CRWD) is acquiring SGNL and Seraphic Security to expand its identity security and browser protection capabilities. The company is growing its Global Data Sovereignty initiative with new in country cloud deployments in Saudi Arabia, India, and the UAE. CrowdStrike has launched a partnership with Nord Security to bring AI powered cybersecurity tools to small and midsize businesses. CrowdStrike builds cloud based cybersecurity tools that help customers protect...

If you are wondering whether Incyte's recent share price puts it at a bargain or a stretch, this article walks through what the numbers are currently saying about value. Incyte's stock closed at US$102.62, with a 39.7% return over the last year and 22.7% over three years, while short term moves have been muted with a 0.8% decline over 7 days, a 0.1% decline over 30 days, and a 1.2% return year to date. Recent attention on Incyte has centered on how its product portfolio and pipeline updates...

In January 2026, Citigroup reported higher full-year net interest income and net income for 2025, while continuing sizable share repurchases totaling about US$14.35 billion and issuing multiple new callable senior and subordinated notes across various maturities. Alongside these capital actions, management signaled that its multi-year transformation is more than 80% complete and reaffirmed confidence in U.S. economic resilience, framing Citi’s balance sheet reshaping as part of a broader...

If you are wondering whether IDEAYA Biosciences' current share price fairly reflects its potential, this article will walk through what the numbers are actually saying about value. The stock last closed at US$35.75, with returns of 1.9% over 7 days, 6.6% over 30 days, 5.6% year to date, 54.4% over 1 year, 111.8% over 3 years and 103.0% over 5 years, which will naturally have some investors reassessing the balance between opportunity and risk. Recent news coverage has focused on IDEAYA...

On Holding (ONON) drew fresh attention after Goldman Sachs upgraded the stock, citing recent holiday demand, strength in China sales, and the potential for margin improvement as key supports for renewed investor interest. See our latest analysis for On Holding. Even with the Goldman Sachs upgrade, recent trading has been choppy, with a 1-month share price return of 9.16% and a 7-day share price return of a 6.64% decline. The 3-year total shareholder return of 102.48% contrasts sharply with...

Why tariffs and competition are suddenly in focus for Trade Desk investors Trade Desk (TTD) is back on investors’ radar after President Trump threatened a 10% tariff on European goods, a move that could pressure ad budgets for export heavy clients using its platform. See our latest analysis for Trade Desk. Those tariff headlines have hit just as Trade Desk contends with Kokai transition growing pains and tougher competition from Amazon, with the share price at $34.15 and a 1 year total...

McEwen (MUX) has put its Grey Fox Project in Timmins, Ontario in focus after reporting its year-end 2025 mineral resource estimate, featuring 1.9 million Indicated and 436,000 Inferred gold ounces. See our latest analysis for McEwen. The Grey Fox update comes after a busy start to 2026, including final drill results at the newly acquired Tartan Mine Project in Manitoba. It lands at a time when McEwen’s share price has gained 7.27% over one day, 26.56% over 30 days, and 31.10% year to date,...

If you are wondering whether Open Text is attractively priced today, the recent share moves and current valuation score give you a lot to work with. The stock closed at US$28.80, with a 13.0% decline over the last 7 days and a 13.7% decline over the last 30 days, while the 1 year return stands at 5.3% and the 5 year return at 29.3% decline. These price moves sit against a backdrop of ongoing attention on large software providers and their ability to keep delivering reliable cash flows and...

BXP has completed more than $1.0b of property sales, including residential, land, and non core office assets. The transactions occurred across several key gateway markets as part of a multi year portfolio optimization plan. These sales contribute to BXP's progress toward its $1.9b asset disposition target for 2025 to 2027. For investors watching NYSE:BXP, the latest $1.0b plus in completed property sales comes at a time when the stock trades around $65.63. Recent share performance has been...

Eastman Chemical: Recent Returns and Business Snapshot With no single headline event driving attention today, Eastman Chemical (EMN) is drawing interest as investors weigh its mixed share performance over the past year against current financial metrics and business fundamentals. The stock shows a 1 day return of about 3.6% decline and a 7 day return of about 2.8% decline, while the month return is about 4.1% and the past 3 months return is about 8.2%. Year to date, the stock return is about...

Parker-Hannifin (NYSE:PH) has agreed to acquire Filtration Group to expand its filtration and aftermarket footprint. The deal will be funded with a mix of new debt and cash, reflecting a commitment to building recurring revenue streams. The acquisition focuses on replacement parts and aftermarket demand, an area that can support more stable, repeat business. Parker-Hannifin enters this transaction with its shares at $929.49, after a 38.3% return over the past year and a very large return...

Wondering whether Intellia Therapeutics at US$12.83 is offering value or just another volatile biotech story? This article walks through what the current price really implies. The stock has returned 9.3% over the last 7 days, 39.0% over the past month, 39.3% year to date and 29.1% over the past year, while the 3 year and 5 year returns of 66.7% and 80.0% declines highlight how sharp previous pullbacks have been. These moves sit against a backdrop of ongoing interest in gene editing companies...

If you are wondering whether Toast at around US$32.76 is priced for its potential or already running ahead of itself, you are not alone. The stock is down 5.9% over the last week, 9.6% over the last month, 3.7% year to date, and 15.2% over the last year, although its 3 year return sits at 52.7%. These moves have kept Toast on many investors' watchlists as the market reassesses what it is willing to pay for high growth, software driven businesses. In that context, valuation tools and checks...

D.R. Horton (DHI) opened fiscal Q1 2026 with revenue of US$6.9b and basic EPS of US$2.03, putting a fresh quarterly snapshot alongside a trailing twelve month EPS of US$11.07 on revenue of US$33.5b and net income of US$3.3b. Over the past year, the company has seen quarterly revenue range from US$7.6b to US$10.0b and basic EPS move between US$2.03 and US$3.95, giving investors a clear view of how the current print sits within recent trading conditions and setting the stage for a closer look...

If you are wondering whether Blue Bird's current share price still offers value, the key question is how the market is weighing its recent performance against what the business could justify over time. The stock last closed at US$49.08, with returns of 0.3% over the past week, a 5.1% decline over 30 days, a 5.0% gain year to date and 16.7% over the last year, plus a very large return over three years and a 127.4% gain over five years. Recent headlines around Blue Bird have focused on the...

In January 2026, AOP Health US announced broader U.S. distribution of its critical care beta-blocker Rapiblyk through McKesson, Cardinal, Cencora Specialty Distribution, and M&D Specialty Distribution, while the Centers for Medicare & Medicaid Services again recognized McKesson as a Qualified Clinical Data Registry supporting oncology practices. CMS’s decision to retain McKesson’s oncology quality measures in the 2026 Advancing Cancer Care MIPS Value Pathways underscores the company’s...